News

Investing.com -- Truist analysts raised their price target on Amazon (NASDAQ: AMZN) shares to $250 from $226 in a note ...
Bernstein analysts remain bullish on Starbucks (NASDAQ: SBUX), stating the stock could double from its post-second quarter ...
KeyBanc Capital Markets initiated coverage of Cava Group with an Overweight rating and a $100 price target, arguing the fast-growing chain has the brand, returns and white space to build a long-term ...
Investing.com -- Dianthus Therapeutics (NASDAQ: DNTH) stock rose 5.8% after receiving its 13th buy rating, with William Blair analyst Mylers Minter initiating coverage with an Outperform rating.
Investing.com -- Tesla delivered 384,122 vehicles in the second quarter of 2025, falling short of Wall Street’s consensus ...
Oscar, a digital-focused insurer operating exclusively on the Affordable Care Act exchanges, laid out plans in June to more than double margins and deliver $2.25+ per share profit by 2027. Barclays is ...
The permit for WeRide’s Robovan W5 marks the company’s second active road testing authorization, following an earlier approval in Guangzhou’s Nansha District in April. This makes WeRide the first and ...
The collaboration will allow Wix merchants to grow their global wholesale capabilities through Alibaba.com, while Alibaba.com ...
Investing.com -- Shares of Centene (NYSE: CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance, citing unexpectedly poor risk adjustment results in the ...
Wolfe Research downgraded Stellantis (NYSE: STLA) to Underperform in a note Wednesday, citing structural challenges and macroeconomic headwinds that could weigh o ...
Redburn Atlantic downgraded Adobe (NASDAQ: ADBE) shares to Sell from Neutral, flagging mounting risks to its competitive ...
Investing.com -- Instil Bio Inc (NASDAQ: TIL) stock surged 10% after the clinical-stage biopharmaceutical company announced the clearance of an Investigational New Drug (IND) application for AXN-2510 ...